HURN Stock Forecast & Price Target

Huron Consulting Gr is well positioned because its healthcare, education, and commercial practices address clients facing structural pressure, while its “shoulder-to-shoulder” implementation work is hard to disintermediate and increasingly supported by AI-driven efficiency gains. The Healthcare segment, which generates a majority of revenue, benefits from non-discretionary demand tied to low-single-digit margins or operating losses at providers, and revenue cycle managed services are growing quickly at mid-20s segment margins. Recent results reinforced the thesis, with total revenue of $443.7 million up 12% year over year, adjusted EBITDA of $50.6 million, and management guiding to 2026 revenue of $1.78 billion to $1.86 billion and 14.5% to 15.0% adjusted EBITDA margin.

Huron Consulting Gr is facing a weakening fundamental setup because, despite long-term demand in healthcare and education, its core markets remain structurally pressured by federal funding changes, declining college-age populations, lower international enrollment, and limits on tuition pricing. While Healthcare still generates 50% of revenue and Commercial grew 22% y/y to $91.0 million, operating income margin of 8.2% missed expectations and cash flow from operations deteriorated to ($162.2) million, signaling that growth is coming with poorer cash conversion and rising cost intensity. The stock’s EV/NTM EBITDA multiple has compressed to 9.9x from 14.3x at the beginning of 2026, but that de-rating is justified if CY24’s expected YOY revenue improvement fails to materialize amid continued macro volatility.